Betulinic acid selectively increases protein degradation and enhances prostate cancer-specific apoptosis: possible role for inhibition of deubiquitinase activity.
Inhibition of the ubiquitin-proteasome system (UPS) of protein degradation is a valid anti-cancer strategy and has led to the approval of bortezomib for the treatment of multiple myeloma. However, the alternative approach of enhancing the degradation of oncoproteins that are frequently overexpressed...
Main Authors: | Teresita Reiner, Ricardo Parrondo, Alicia de Las Pozas, Deanna Palenzuela, Carlos Perez-Stable |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3570422?pdf=render |
Similar Items
-
ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells
by: Ricardo Parrondo, et al.
Published: (2013-09-01) -
NF-κB activation enhances cell death by antimitotic drugs in human prostate cancer cells
by: Parrondo Ricardo, et al.
Published: (2010-07-01) -
Epidithiodiketopiperazines inhibit protein degradation by targeting Proteasome Deubiquitinase Rpn11
by: Li, Jing, et al.
Published: (2018) -
Broad Spectrum Deubiquitinase Inhibition Induces Both Apoptosis and Ferroptosis in Cancer Cells
by: Li Yang, et al.
Published: (2020-06-01) -
Deubiquitinases in Cancers: Aspects of Proliferation, Metastasis, and Apoptosis
by: Jiaqi LIU, et al.
Published: (2022-07-01)